Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial

• Main Authors: Carsten Flohr (Author), Michael J. Cork (Author), Michael R. Ardern-Jones (Author), Lawrence F. Eichenfield (Author), Sébastien Barbarot (Author), Claire Feeney (Author), Ricardo Rojo (Author), Irina Lazariciu (Author), John Nesnas (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background Differences in atopic dermatitis (AD) disease course and manifestation with age may extend to treatment response. Objective To evaluate response maintenance with continuous-/reduced-dose abrocitinib or withdrawal and response to treatment reintroduction after flare in adolescent and adult...